Certara, Inc. (CERT) SEC Filings & Earnings Calls

Revenue growth guidance of 0-4% indicates low growth; services revenue declining.

“We continue to expect full-year revenue growth of 0% to 4% on a comparable continuing operations basis.” · word for word

Restructuring and divestiture execution risk.

“Certara executed a reduction in force, impacting approximately 5% of its global employee base.”

Loss of key commercial leadership; transition risk.

“Departure of President and Chief Commercial Officer; retained as Senior Advisor until December 31, 2026.”

Declining net retention rate

“Net Retention Rates 106.1 % 101.5 % 102.4 % 107.6 %” · word for word

Loss from discontinued operations

“Total loss from discontinued operations, net of tax $ (49,189) $ (3,464)” · word for word

High G&A expense growth

“General and administrative expenses increased by $5.2 million, or 31%, to $21.9 million for the three months ended June 30, 2026” · word for word

Negative operating cash flow trend

“Net cash provided by operating activities of continuing operations $ 15,584 $ 23,329”

Foreign exchange volatility

“Currency (gain) loss(a) 2,358 (577)” · word for word

CFO departure may create transition risk, but interim appointment and guidance reaffirmation mitigate.

“CFO resignation; interim CFO appointed; guidance reaffirmed.”

Regulatory Reversal Risk

“Changes in government or regulatory policy, or a reversal in the trend toward increasing the acceptance of and reliance upon in silico data in the drug approval process, could decrease the demand for our products and services.” · word for word

Government Funding Pullback

“Furthermore, in the past year, there has been a general pullback of government support and funding for drug development, particularly for public sector and academic organizations, dependent on outside funding to develop early-stage research.” · word for word

Macroeconomic Uncertainty

“Uncertain macroeconomic conditions, including higher inflation, rising interest rates and instability in the financial system, trade disputes, tariffs, changes in government funding, geopolitical conflicts, and pandemics or other infectious disease outbreaks, may pose challenges to our business.” · word for word

Services revenue and bookings declining, indicating execution and go-to-market challenges.

“Services revenue -4% YoY, Services bookings -14% YoY”

Divestiture may reduce revenue diversification but provides cash infusion.

“Sale of Business for $100M cash plus earnout.”

Loss of audit committee member may require replacement; minimal operational risk.

“Resignation from Audit Committee of the Board.”

Goodwill Impairment Risk

“Impairment of goodwill or other intangible assets may adversely impact future results of operations.” · word for word

High Leverage and Debt Service

“As of December 31, 2025, we had $295.5 million in total borrowings under our credit agreement... and $100.0 million of capacity outstanding under our revolving credit facility.” · word for word

Regulatory Policy Reversal

“Changes in government or regulatory policy, or a reversal in the trend toward increasing the acceptance of and reliance upon in silico data in the drug approval process, could decrease the demand for our products and services.” · word for word

FY2026 revenue growth guidance of 0-4% indicates potential slowdown; software bookings decline in Q4.

“FY2026 revenue growth 0-4%; Q4 software bookings -6% YoY.”

Leadership uncertainty from executive departure.

“executive transition” · word for word

Regulatory policy reversal

“Changes in government or regulatory policy, or a reversal in the trend toward increasing the acceptance of and reliance upon in silico data in the drug approval process, could decrease the demand for our products and services.” · word for word

Government shutdown impact

“If the government shutdown continues for an extended period, it could increase uncertainty in the overall economic environment and adversely impact business operations across multiple industries, including the pharmaceutical industry.” · word for word

Spending hesitancy in regulatory services, especially from tier-one customers; services bookings declined 9% YoY.

“Services bookings $55.8M, -9% YoY; softer trends among tier-one customers in Regulatory services.”